See more : Dermata Therapeutics, Inc. (DRMA) Income Statement Analysis – Financial Results
Complete financial analysis of Verano Holdings Corp. (VRNOF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Verano Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Cypark Resources Berhad (5184.KL) Income Statement Analysis – Financial Results
- Vitesco Technologies Group Aktiengesellschaft (VTSCF) Income Statement Analysis – Financial Results
- Pro-Pac Packaging Limited (PPG.AX) Income Statement Analysis – Financial Results
- Zillow Group, Inc. Class C (Z) Income Statement Analysis – Financial Results
- Sunny Optical Technology (Group) Company Limited (SOTGY) Income Statement Analysis – Financial Results
Verano Holdings Corp. (VRNOF)
About Verano Holdings Corp.
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 938.45M | 879.41M | 737.85M | 290.79M | 85.66M |
Cost of Revenue | 463.25M | 456.35M | 403.29M | 118.29M | 38.86M |
Gross Profit | 475.21M | 423.06M | 334.56M | 172.50M | 46.80M |
Gross Profit Ratio | 50.64% | 48.11% | 45.34% | 59.32% | 54.63% |
Research & Development | 0.00 | 1.17M | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 179.54M | 233.83K | 57.96K |
Selling & Marketing | 0.00 | 0.00 | 8.64M | 0.00 | 1.20M |
SG&A | 331.93M | 356.57M | 188.18M | 233.83K | 57.96K |
Other Expenses | 58.49M | 116.15M | 41.78M | 0.00 | 0.00 |
Operating Expenses | 390.12M | 472.72M | 229.97M | 233.83K | 57.96K |
Cost & Expenses | 853.36M | 929.07M | 633.25M | 233.83K | 57.96K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 59.79M | 49.43M | 24.27M | 13.31M | 5.64K |
Depreciation & Amortization | 151.63M | 150.33M | 96.24M | 10.01M | 9.60M |
EBITDA | 239.22M | 36.35M | 169.50M | 97.76M | 5.58M |
EBITDA Ratio | 25.49% | 15.22% | 28.94% | -0.08% | -0.07% |
Operating Income | 84.78M | -16.46M | 107.68M | -233.83K | -57.96K |
Operating Income Ratio | 9.03% | -1.87% | 14.59% | -0.08% | -0.07% |
Total Other Income/Expenses | -56.99M | -2.27M | -19.88M | -9.85M | -5.64K |
Income Before Tax | 27.80M | -163.40M | 91.96M | -249.02K | -63.60K |
Income Before Tax Ratio | 2.96% | -18.58% | 12.46% | -0.09% | -0.07% |
Income Tax Expense | 145.15M | 105.47M | 104.13M | 15.19K | -3.26K |
Net Income | -117.35M | -268.87M | -12.17M | -264.22K | -60.34K |
Net Income Ratio | -12.50% | -30.57% | -1.65% | -0.09% | -0.07% |
EPS | -0.34 | -0.81 | -0.04 | 0.00 | 0.00 |
EPS Diluted | -0.34 | -0.81 | -0.04 | 0.00 | 0.00 |
Weighted Avg Shares Out | 344.07M | 331.41M | 287.54M | 290.00M | 290.00M |
Weighted Avg Shares Out (Dil) | 342.77M | 331.41M | 290.44M | 290.00M | 290.00M |
Top US Marijuana Stocks to Watch in August 2024
Verano Enters into Agreements with The Cannabist Company to Acquire One of Its Virginia Licenses and Associated Operations and Its Arizona Operations
Verano Announces the Opening of Zen Leaf Fairless Hills, the Company's Newest Affiliated Dispensary in Pennsylvania, in Prime New Location
3 Marijuana Stocks To Start Your Week Off With Better Investing
3 Marijuana Stocks To Watch Mid-July
Marijuana Stocks For Cannabis Investors To Watch Today
3 Cannabis Stocks to Buy Ahead of the 2024 Presidential Election
Cannabis companies to appeal federal commerce clause lawsuit
Verano to Report Second Quarter 2024 Financial Results on August 7, 2024
3 Marijuana Stocks To Watch In July 2024
Source: https://incomestatements.info
Category: Stock Reports